Video

VIDEO: Sodium zirconium cyclosilicate seen as efficacious, safe for treatment of hyperkalemia

SAN DIEGO — In this exclusive video from ASN Kidney Week 2018, Ian Sabir, June Zhao, MD, PhD and Ayman Al-Shurbaji, MD, PhD, discuss a phase III study that compared 5 g and 10 g of Lokelma (sodium zirconium cyclosilicate, AstraZeneca) with placebo for the treatment of hyperkalemia.

SAN DIEGO — In this exclusive video from ASN Kidney Week 2018, Ian Sabir, June Zhao, MD, PhD and Ayman Al-Shurbaji, MD, PhD, discuss a phase III study that compared 5 g and 10 g of Lokelma (sodium zirconium cyclosilicate, AstraZeneca) with placebo for the treatment of hyperkalemia.

    See more from American Society of Nephrology Annual Meeting